Document is current
Any future updates will be listed below
-
Authors
Cordioli, Maddalena https://orcid.org/0000-0002-4804-2379
Gios, Lorenzo
Erbogasto, Anna
Mirandola, Massimo
Sandri, Angela
Padovese, Valeska
Caceres, Carlos
Vargas, Silver
Blondeel, Karel
Silva, Ronaldo
Kiarie, James
Kurbonov, Firdavs
Peeling, Rosanna W.
Thwin, Soe Soe
Golparian, Daniel
Unemo, Magnus
Toskin, Igor
,
-
Funding
Funding for this research was provided by:
UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research
Development and Research Training in Human Reproduction
- License Information
-
More Information
Article History
Received: 5 April 2023
Accepted: 19 January 2024
First Online: 29 February 2024
Declarations
:
: The core protocol upon which this study was based was independently peer reviewed and approved by the Research Project Review Panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research (SRH) and by the WHO Ethics Review Committee (ERC). The protocol has also been adapted to the individual countries and approved by RP2, ERC, and institutional review boards at each site. Details are provided in elsewhere [].
: Not applicable.
: The POCT manufacturer disclose and furnish free of charge to WHO the information and sufficient quantities of the product in order to enable this evaluation as part of the WHO/RHR STI POC initiative. WHO is entitled to evaluate and publish the trial results, and to exclusively control this evaluation and the content of the aforesaid publication. WHO shall submit any proposed publication to the manufacturers for review, comments received will be considered in good faith, but the decision to publish rests with WHO.
